Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, MD
9 recruiting Phase 1/2 multiple sclerosis studies in the US. What trial phases mean
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, MD
Sponsor: Tr1X, Inc.
La Jolla, CA · Kansas City, KS · Rochester, MN · +5 more sites
Sponsor: UniQure Biopharma B.V.
Birmingham, AL · Phoenix, AZ · Palo Alto, CA · +15 more sites
Sponsor: University of California, San Francisco
San Francisco, CA
Sponsor: Brigham and Women's Hospital
Boston, MA
Sponsor: Brigham and Women's Hospital
Boston, MA
Sponsor: Ashvattha Therapeutics, Inc.
San Francisco, CA · Stanford, CA · Jacksonville, FL
Sponsor: AbelZeta Inc.
Gilbert, AZ · La Jolla, CA
Sponsor: University of California, San Francisco
San Francisco, CA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.